These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35180067)

  • 1. Scleral Plaques in Nephrogenic Systemic Fibrosis.
    Dreyer S; Rodriguez L; Worswick S
    Cutis; 2022 Jan; 109(1):E31-E32. PubMed ID: 35180067
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrogenic fibrosing dermopathy.
    Ragunatha S; Palit A; Inamadar AC; Madraki RM; Yelikar BR
    Indian J Dermatol Venereol Leprol; 2009; 75(1):63-7. PubMed ID: 19172035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR; Jagirdar J
    J Comput Assist Tomogr; 2008; 32(1):1-3. PubMed ID: 18303280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoxanthoma elasticum-like changes in longstanding gadolinium-naïve nephrogenic systemic fibrosis in a patient with chronic kidney disease.
    Das A; Nair SP; Kumar GN; Mathew R; Bindu RS; Mathew R; Gopinath DV
    Indian J Dermatol Venereol Leprol; 2022; 88(3):401-403. PubMed ID: 35389021
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular pathologic features and gadolinium deposition in nephrogenic systemic fibrosis.
    Barker-Griffith A; Goldberg J; Abraham JL
    Arch Ophthalmol; 2011 May; 129(5):661-3. PubMed ID: 21555622
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrogenic Systemic Fibrosis in the Setting of Transient Renal Insufficiency.
    Dinh H; Phan J; Lountzis NI; Purcell SM
    Cutis; 2021 Dec; 108(6):342-344. PubMed ID: 35167789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
    Bernstein EJ; Schmidt-Lauber C; Kay J
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):489-503. PubMed ID: 23040363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic systemic fibrosis: a case report and review of the literature.
    Truong SV; Chen JK; Reinstadler A; Saedi N
    J Drugs Dermatol; 2011 Jun; 10(6):622-4. PubMed ID: 21637902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephrogenic systemic fibrosis: a severe complication of use to gadolinium in patients with kidney failure].
    Mundim JS; Lorena Sde C; Abensur H; Elias RM; Moysés RM; Castro MC; Romão Júnior JE
    Rev Assoc Med Bras (1992); 2009; 55(2):220-5. PubMed ID: 19488662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrogenic systemic fibrosis].
    Becker S; Witzke O; Kribben A
    Med Klin (Munich); 2009 Mar; 104(3):204-9. PubMed ID: 19337710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K; Ezell LD; Macklin JG
    Nephrol Nurs J; 2007; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: clinical aspects.
    Piera-Velázquez S; Sandorfi N; Jiménez SA
    Skinmed; 2007; 6(1):24-7. PubMed ID: 17215616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic fibrosing dermopathy: report of two cases.
    Aires NB; Sotto MN; Nico MM
    Acta Derm Venereol; 2007; 87(6):521-4. PubMed ID: 17989891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic systemic fibrosis: a concise review for cardiologists.
    Cheong BY; Muthupillai R
    Tex Heart Inst J; 2010; 37(5):508-15. PubMed ID: 20978560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrogenic fibrosing dermopathy].
    Brisch M; Schneider T; Requena L; Mentzel T; Kutzner H
    J Dtsch Dermatol Ges; 2003 Jun; 1(6):464-7. PubMed ID: 16295140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is your diagnosis. Nephrogenic systemic fibrosis.
    Zaleski L; Xia Y; Cho S
    Cutis; 2011 Jan; 87(1):13, 19-20. PubMed ID: 21323094
    [No Abstract]   [Full Text] [Related]  

  • 17. Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Jamboti J
    Intern Med J; 2007 Jul; 37(7):508-9; author reply 509. PubMed ID: 17547734
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nephrogenic fibrosing dermopathy and systemic fibrosis as complication of MR contrast media in patients with chronic renal failure].
    Buĭlov VM
    Urologiia; 2008; (5):63-6. PubMed ID: 19086232
    [No Abstract]   [Full Text] [Related]  

  • 19. CT and MR imaging of progressive dural involvement by nephrogenic systemic fibrosis.
    Zelasko S; Hollingshead M; Castillo M; Bouldin TW
    AJNR Am J Neuroradiol; 2008 Nov; 29(10):1880-2. PubMed ID: 18854445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy).
    Galan A; Cowper SE; Bucala R
    Curr Opin Rheumatol; 2006 Nov; 18(6):614-7. PubMed ID: 17053507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.